Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03016819
Title A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma (APROMISS)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Advenchen Laboratories, LLC
Indications

synovial sarcoma

cutaneous leiomyosarcoma

bone leiomyosarcoma

leiomyosarcoma

alveolar soft part sarcoma

Therapies

Anlotinib

Dacarbazine

Age Groups: adult | senior
Covered Countries USA | ITA | ESP


No variant requirements are available.